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ABSTRACT Fluorescent labels are often used in bioassays as a means to detect and characterize ligand-receptor binding.
This is due in part to the inherently high sensitivity of ﬂuorescence-based technology and the relative accessibility of the tech-
nique. There is often little concern raised as to whether or not the ﬂuorescent label itself affects the ligand-receptor binding
dynamics and equilibrium. This may be particularly important when considering nanoparticle labels. In this study, we examine
the affects of nanoparticle (quantum dots and polymer nanospheres) ﬂuorescent labels on the streptavidin-biotin binding sys-
tem. Since the nanoparticle labels are larger than the species they tag, one could anticipate signiﬁcant perturbation of the bind-
ing equilibrium. We demonstrate, using ﬂuorescence cross-correlation spectroscopy, that although the binding equilibria do
change, the relative changes are largely predictable. We suggest that the nanoparticles’ mesoscopic size and surface tension
effects can be used to explain changes in streptavidin-biotin binding.
INTRODUCTION
The quantification of ligand-receptor binding interactions is
at the heart of understanding signal transduction in biologi-
cal systems. Moreover, membrane-bound receptor proteins
comprise more than 50% of potential targets and available
prescription pharmaceuticals (1). For reasons of convenience,
history, and accessibility, the majority of binding/kinetic in-
formation is derived from radiolabeling and/or fluorescence
assays. Although tagging ligands with fluorescent labels pro-
vides a convenient method for monitoring both equilibria
and dynamics in solution, the impact of labeling on the very
property being measured may be significant. Therefore, one
needs to ensure that the ligand binding information being
extracted remains physiologically relevant.
We examine to what extent the natural equilibrium of the
biotin-streptavidin model system is affected by the conju-
gation to bulky fluorescent nanoparticle labels. Furthermore,
we wish to determine whether or not any observed changes in
the native equilibrium can be correlated to the mesoscopic
property of label size. In doing so, we hope to gain insight
into how other ligand-receptor systems of interest may be
affected by fluorescent labeling, which in turn may provide
rationalization for the selection of fluorescent labels in future
fluorescence-based bioassays.
To analyze any biomolecule of interest, one must first be
able to distinguish and quantify the amount of the target
molecule in an often complex mixture. Thus, it is common
practice to utilize easily detectable labels for identification
and measurement purposes. These labels, which report on the
behavior of the biomolecule of interest, can be radioactive
isotopes (e.g., 3H or 35S), spin probes (e.g., 13C), or fluo-
rescent probes. Isotopic labeling of biomolecules has many
advantages, including a high sensitivity of detection, typi-
cally in the picomolar-femtomolar range (1012–1015 M)
(2). Despite the increased sensitivity and ease of radioassays,
isotopic labeling requires very stringent safety regulations
and practices, including specialized waste disposal. Fur-
thermore, the introduction of heavier atoms can alter the
equilibrium kinetics of sensitive ligand-receptor and enzyme-
substrate reactions (3).
Target-directed fluorescent probes can be generated
through the conjugation of fluorescent molecules such as
rhodamine 6G or fluorescein to substrates, ligands, or pro-
teins, resulting in a specific probe for the receptor/enzyme
of interest. The widespread accessibility of commercially
available fluorescent biomolecules and ease of labeling have
resulted in a large number of absorbance and fluorescence-
based assays. However, fluorescence-based measurements of
Kd values below 10
8 M have proven to be difficult (4). In-
conveniently, nonspecific interactions (association of the dye
moiety with the lipid bilayer) may become significant at these
concentrations, leading to high background and further
complicating data analysis (5).
Additional issues surrounding the use of fluorophores as
conjugates to small ligands/substrates include the potential to
alter the natural equilibria and physiological effect of these
biomolecules, often more substantially than that resulting
from isotope labeling. AlexaFluor 488 (AF 488), a com-
mercially available fluorophore, has a molecular weight of
;885 g/mol; and a representative small drug, morphine, has
a formula weight of ;285 g/mol. In the above example, it is
noted that the molecular mass of the fluorescent tag is ;4
times larger than the ligand/drug which one may want to
label. This substantial increase in molecular mass results in a
reduced diffusion coefficient for the ligand in solution.
Added bulk from the fluorophore also restricts the rotational
motion of ligands in solution, which reduces the probability
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that the ligand will find the correct orientation for binding.
The implications of reduced freedom of motion manifest in
potential changes to the equilibrium binding rate constants
and overall affinity of the ligands for the receptors.
Although various labeling and detection methods have
allowed the explication of a myriad of biochemical infor-
mation from molecules which otherwise would prove diffi-
cult to study, the effect of fluorescent labeling has been slow
to arrive. Some effort has been made to quantify this effect
both experimentally and theoretically. Experimental studies
examining the effect of a covalently attached extrinsic fluoro-
phore to proteins have returned conflicting results. Gajraj and
Ofoli (7) noted that labeling bovine serum albumin (BSA)
with fluorescein-isothiocynate molecules affected both the
diffusion and adsorption behavior of the protein. Functional
studies carried out by Zimmerman et al. (8) on labeled ly-
sozymes report little to no change in the enzymatic activity
when compared to unlabeled lysozymes. This suggests that
fluorescent labels have little effect on their biological activity.
Rosenthal and co-workers (9,10) have studied the effects of
coupling membrane receptor proteins and ligands to quantum
dots (QDs) and found that with long linker molecules,
binding is largely unaffected. Importantly, many of these
studies focused on quantifying the effect of labeling for
proteins which are not expected to be affected to the same
extent as small ligands or look at the effect of labeling only
one of the components in the reaction. The study of ligand
binding has been technically challenging.
Increasingly, correlation spectroscopy has been used to
indirectly probe ligand binding by quantifying the loss of free
fluorescently labeled ligand in the presence of the receptor,
both in solution and in living cells (11–14). We have previ-
ously reported a facile method employing the correlation
amplitudes (G(0)s and GX(0)s) derived from fluorescence
correlation spectroscopy (FCS) and fluorescence cross-cor-
relation spectroscopy (FCCS), respectively (13,16). In both
techniques the amplitudes are related to the concentrations of
the labeled species in solution and, therefore, can be used to
determine the concentration of bound species directly. FCCS
has also been applied to protein-protein (7,17), DNA-DNA
(18,19), and lipid-DNA (20) interactions and vesicle fusion
(21). In two-photon excitation (TPE)-FCCS, both the ligand
and the receptor are fluorescently labeled, thereby increasing
any labeling effects which may be present. Conveniently,
however, the decay curves obtained for individual autocor-
relation and dually labeled cross-correlation decays can be fit
to obtain information about the hydrodynamic radii of the
two components (13,16). This information cannot be ob-
tained from standard macroscopic fluorescence and radioli-
gand assays; it provides additional means by which one can
quantify the observed effects of labeling on both the small
ligand and the larger receptor.
As mentioned above, we used the streptavidin-biotin sys-
tem in this study of nanoparticle labeling. For this study
of nanoparticle labeling, we chose to examine the well-
characterized streptavidin-biotin system. FCCS was previ-
ously used in binding assays involving nanoparticle-labeled
streptavidin-biotin interactions. Hwang and Wohland’s (22)
proof of principle used organic dye labeled streptavidin and
biotin to demonstrate one-color single photon excitation
FCCS for ligand-receptor binding. In their communication,
Hwang and Wohland also presented evidence for binding
between biotinylated fluorescein and a streptavidin-func-
tionalized QD (655 nm). We recently used TPE-FCCS to
probe streptavidin-biotin binding, each with QD labels (13),
developing a method to directly measure the fractional oc-
cupancy, PA, of the receptor and used this parameter to de-
termine Kd and the ligand/receptor ratio. Semiconductor
nanocrystals (i.e., QDs) (23) are increasingly being used as
labels of biomolecules in fluorescence correlation spectros-
copy (24,25), owing largely to their extreme brightness,
which allows single molecule detection with relative ease.
Our recent results describing the proof of principle to use
QDs in streptavidin-biotin binding assays suggested that
further study of the nanoparticle label effect on binding was
warranted (13). Additionally, a biophysical understanding
linking biomacromolecules using the streptavidin-biotin
‘‘bond’’ is of increasing importance. For comparative pur-
poses, the relative structures and sizes of the systems studied
here are shown in Fig. 1.
The idea that biotin and streptavidin act as ‘‘molecular
Velcro’’ and form a very strong bond (Kd; 10
14 M) has led
to their widespread use in many areas of science, including
chemistry, biochemistry, physics, and even some medical/
clinical applications (26). As such, the entire list of applica-
tions are too numerous to mention here, and a few examples
will be presented to highlight the pervasive utilization of this
ligand-receptor pair.
Tian et al. (27) have used the biotin-streptavidin linkage to
create complex DNA templates for eventual use in DNA-
based nanoelectronics. In a similar application, Lee et al. (28)
employed the biotin-streptavidin pair in the construction of
an ion channel biosensor switch. Recently, Rissin and Walt
(29) demonstrated that it was possible to achieve attomolar
detection limits using enzyme-amplified femtomolar arrays
based on the biotin-streptavidin system. With respect to
clinical applications, Hamblett et al. (26) discuss the possible
use of biotin and streptavidin for specific tumor targeting and
cancer therapeutics. They proposed injecting the patient with
monoclonal antibodies, which are conjugated to streptavidin,
for the tumor of interest. After an incubation period, the pa-
tient was injected with radiolabeled biotin to target radiation
therapy (26). For this particular clinical application to be
effective, it is imperative that the labeled biotin and strepta-
vidin, ligand, and receptor retain their physiological binding
activity.
Although the applications of biotin-streptavidin are di-
verse in nature, the rationale behind the use of this ligand-
receptor pair typically is that it is the ‘‘strongest noncovalent
interaction’’ (25). Indeed the strong noncovalent binding of
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the system is valid for an unlabeled biotin-streptavidin sys-
tem. However, one can imagine that the conjugation of
anything to either biotin or streptavidin may alter its native
equilibrium. Our study investigates what effect the conju-
gation of bulky appendages (nanoparticle fluorophores in this
case) has on the equilibrium binding and association/disso-
ciation kinetics of this popular ligand-receptor pair.
MATERIALS AND METHODS
Commercial biotin and streptavidin conjugates
All materials were purchased from the suppliers and used without further
purification. AF conjugates of streptavidin 488 and 594 (AFS488 and
AFS594, respectively) were obtained as lyophilized powder (Molecular
Probes, Eugene, OR). Stock solutions were prepared by dissolving 1 mg of
the sample in 5 mL of 100 mM phosphate buffer (PB; pH 7.2, 0.1% BSA).
Once dissolved, the sample vials were covered with aluminum foil and stored
at 6C. Using amolecular mass of;52 kDa for the streptavidin and;820Da
for the AF dye, the total mass of the labeled receptor was estimated to be
;54,500 Da. This mass was used to determine the molarity of the stock
solution (;3.7 3 106 M). For all titration assays, the stock was diluted to
;10 nM working solutions in the desired buffer for both the AFS488 and
AFS594 conjugates. Typically, 1 nM streptavidin solutions were used for
titration purposes.
FluoSphere conjugates of biotin (FSB) and streptavidin (FSS) were ob-
tained and used as delivered (Invitrogen, Burlington, Ontario, Canada).
Streptavidin-conjugated spheres (40 nm) as well as two samples of different
sized biotinylated spheres (40 and 200 nm) were employed to dramatically
alter the size of the ligand. All three conjugated FluoSphere beads had one-
photon absorption and emission wavelength maxima in the yellow/green
region of the spectrum (505/515, respectively). The concentration of the
FluoSphere conjugates was determined using Eq. 1 (30):
FS=mL ¼ 6C3 10
12
r3p3f3
: (1)
In Eq. 1 the concentration of suspended beads measured in g/mL is denoted
by C, the diameter of the spheres (in mm) is represented by f, and r is the
density of the polymer in g/mL.
For the polystyrene spheres used here, the density was equal to 1.05 g/mL.
The number of microspheres per ml was converted tomolar concentrations of
spheres (mole/L) for each of the stock solutions. The concentrations for the
40 nm, 200 nm FSB, and 40 nm FSS solutions were 472 nM, 3.8 nM, and
236 nM, respectively. Dilutions of the 40 nm FSB conjugate were made for
titration purposes (5, 10, and 20 nM), whereas the 200 nm FSB solution was
used undiluted. Due to the intense brightness of the 200 nm FSB ligands,
titrations using this particular ligand were carried out with only 50% of the
signal sent to the detectors. Studies were carried out to ensure that the G(0)
andGx(0) values were not affected by the reduced signal to the detectors. For
titrations, FSS receptors were used at the concentration of;1 nM to coincide
with previously reported QDS-QDB titration conditions (13). QD biotin
(QDB605) and streptavidin conjugates (QDS525 and QDS605) were initially
purchased from Quantum Dot (Hayward, CA) and later from Invitrogen. A
number of buffer systems were utilized for the titration assays to quantify the
effect of the total salt concentration on the equilibrium binding constants for
the model system. The buffer systems were prepared from the 100 mM PB
(pH 7.2, 0.1% BSA) by adding increased amounts of NaCl to examine the
effect of ionic strength.
Optical setup
Samples were excited using 780 nm, 100 fs laser light from a Spectra Physics
(Palo Alto, CA) Tsunami laser operating at 82 MHz. The laser power was
attenuated to 20 mW with a neutral density filter to avoid photodamage. The
QDot 605 and the organic fluorophores used all have appreciable TPE
probability at 780 nm. The laser beam was expanded using a Galilean tele-
scope to slightly overfill the back aperture of a 403, 0.9 NA Zeiss objective
lens (working distance ¼ 2 mm) mounted on a Zeiss Axiovert 200 fluores-
cence microscope (Zeiss, Thornwood, NY). The long working distance
objective lens available for this study produces a slightly larger excitation
volume than typical high numerical aperture lenses. TPE fluorescence was
collected by the same objective lens, passed through a broad band-pass filter
to remove laser light (Omega Optical, XF3100, Brattleboro, VT), and re-
flected off a dichroic optic (Chroma, 700DCSPXR, Rockingham, VT) and
through a tube lens in the side port of themicroscope. A second dichroic optic
(Chroma 565DCLP) was used to separate the red and green fluorescence.
The spectrally separated light passes through band-pass filters (Chroma,
E590LPv2 and D535/503 for the red and green emissions, respectively) and
was coupled into optical fibers located at the focus of the tube lens. Using the
optical fibers, the fluorescence was detected by two Si avalanche photodiodes
(APDs; Perkin-Elmer, SPCQ-200, Fremont, CA). The output of the APDs
was analyzed using a correlator card (ALV-5000; ALV, Langen, Germany).
FIGURE 1 Schematic diagram of relative sizes. (A) Bi-
otin. (B) Streptavidin. (C) 525 streptavidin-QD (hydrody-
namic radius, 4 nm). (D) 605 biotinylated-QD (hydrodynamic
radius, 10 nm). (E) Green streptavidin-fluosphere (hydro-
dynamic radius, 20 nm). (F) Green biotinylated fluosphere
(hydrodynamic radius, 100 nm).
Nanoparticles as Fluorescent Labels 867
Biophysical Journal 95(2) 865–876
FCS and FCCS data analysis
To measure the relative concentrations of species needed to determine the
ligand-receptor equilibrium constants and off-rate kinetics, fluorescence
correlation and cross-correlation analyses of the titration solutions were
employed. Autocorrelation decays were modeled assuming a Gaussian TPE
volume using the following equation (13,16):
GðtÞ ¼ GBðSÞð0Þ 11 8DBðSÞt
r
2
0
 1
11
8DEt
z
2
0
 1=2
; (2)
where the subscripts B(S) indicate biotin (or streptavidin) associated fluo-
rescent diffusers, t is the lag time, D is the diffusion constant, r0 is the laser
beam radius at its focus, and z0 is the 1/e
2 radius in the z direction. The TPE
excitation volume was calibrated by measuring the autocorrelation decay for
a 100 nM solution of Alexa 488 (D ¼ 2.8 3 1010 m2/s) in buffer (50 mM
Tris-HCl pH 8.0). The excitation volume was found to be 3.3 fL (r0¼ 7.63
107 m and z0 ¼ 3.0 3 106 m). r0 and z0 were then held constant at these
values. We have shown this method to be valid for calibrating the TPE
volume (12). The meaning of the G(0)s will be presented shortly.
Cross-correlation decays were modeled as above using the following
equation (13,16):
GXðtÞ ¼ GBSð0Þ 11 8DBSt
r
2
0
 1
11
8DBSt
z
2
0
 1=2
; (3)
where the subscript BS represents labeled ligands and receptors which are
physically bound together and thus dual-color labeled. Nonlinear least-
squares fitting to the data were accomplished using the software package
Origin (OriginLab, Northampton, MA). The equations contain no terms to
account for intersystem crossing or intermittent fluorescence, the effects of
which were minimized here by keeping the excitation rates low (13,16,31).
Also, we observed no fluorescence resonance energy transfer or fluorescence
quenching in the case of bound systems. This was verified by the lack of
relative changes in the brightness (count rate per particle) of either species
when both were present in solution.
It was previously demonstrated that the fractional occupancy, PA, could
be calculated simply usingG(0)s (13,16). Briefly, in the absence of cross talk
between the two detection channels, the correlation and cross-correlation
amplitudes are given by
GBðSÞð0Þ ¼ ÆCBðSÞæ1 ÆCBSæ
NA VeffðÆCBðSÞæ1 ÆCBSæÞ2
(4)
and
GBSð0Þ ¼ ÆCBSæ
NA VeffðÆCBæ1 ÆCBSæÞðÆCSæ1 ÆCBSæÞ; (5)
where, NA is Avogadro’s number, Veff is the effective TPE volume, ÆCBSæ is
the time-averaged concentration of dually labeled species, and ÆCB(S)æ is the
time-averaged concentration of biotin (or streptavidin). To use this equation,
one assumes that the correlation amplitude is free of cross talk between the
detection channels. We have previously shown this to be true for the QDs
used in this study (13). Additionally, in the case of low concentrations, the
autocorrelation G(0)s were corrected for the contribution of background
noise as necessary (16).
For the equilibrium B 1 S4 BS, recall that fractional occupancy is
PA ¼ ÆCBSæÆCSæ1 ÆCBSæ (6)
This relation can be expressed in terms of G(0) values as follows:
PA ¼ ÆCBSæÆCSæ1 ÆCBSæ ¼
GBSð0Þ
GBð0Þ (7)
Equation 7 shows that unlike the individual G(0)s, PA is not dependent upon
the TPE volume; however, where a precise calibration of this volume is
available, more information about the system (such as the diffusion coeffi-
cients) can be gained.
Ligand-receptor binding data analysis
The binding data of ligand to receptor were analyzed in the following way.
Since there may be multiple receptors per dot/sphere, one may need to
consider a multiple-ligand equilibrium approach to binding. Thus for n lig-
ands (L) associating with a nanoparticles/spheres (R) we have
nL1R5ðLÞnR; (8)
where n can be a whole number or a fraction.
It can be shown that a standard analysis of this equilibrium produces the
Hill equation for multiligand binding (30):
In
PA
1 PA
 
¼ n InðCLÞ  InK9d; (9)
where PA is, again, the fractional occupancy of available binding sites on the
dot/sphere, CL is the concentration of ligand, and K9d is the dissociation
constant for the equilibrium presented in Eq. 8. Additionally, in the absence
of cooperativity, taking the nth root of the dissociation constant,K9d, gives the
dissociation constant, Kd, for the formation of an individual ligand-receptor
complex. Binding curve titrations were carried out as described previously
(13,16).
Dissociation kinetics
For measuring the off-rate kinetics, equilibria were established such that 1:1
pairs of the streptavidin-biotin systems dominated. We can then give the
following equilibrium equation considering a pair of QD labels:
QDS :QDB4
koff
kon
QDS1QDB: (10)
Free d-biotin is added to measure the off-rate for the above reaction. This can
be approximated as a perturbation that removes free QDS, thus promoting
more dissociation of QDS:QDB to restore equilibrium. Following our
previously developed kinetic equations for the off-rate of the above equation,
we use (13)
PAðtÞ
ðPAÞ0
¼ 1
11DPA
DPA1 e
koff ð11DPAÞt
h i
: (11)
Equation 11 has only one adjustable parameter, koff, which represents the rate
constant of QDS:QDB unbinding. DPA ¼ PA(N)/(PA(0)–PA(N)). The
derivation of this equation can be found in Briddon et al. (12).
RESULTS AND DISCUSSION
Fluorescent label size versus equilibrium
binding constant
The streptavidin-biotin binding equilibrium was previously
examined with respect to QD labels (13). In that study, we
established that although the reduced association is not solely
governed by increased ligand and receptor bulk, the added
mass and dimension of the QD label reduced the binding
constant by a relatively large factor (;3600 times) and thus
could not be neglected. To further quantify how the bulky
nature of the fluorescent label affects the equilibrium binding
kinetics of our model system, several different sized conju-
gated biotin and streptavidin species were studied. To es-
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tablish which of the ligands was more affected by the bulky
fluorescent label, the sizes of the streptavidin and biotin
conjugates were systematically varied.
To understand and quantify the binding between various
fluorophore-labeled streptavidin and biotin moieties, titra-
tions were performed as described in Swift et al. (13). A
series of FCCS decays for a titration of streptavidin-func-
tionalized fluospheres (40 nm diameter, green emission) with
biotinylated QDs (20 nm diameter, red emission) is presented
in Fig. 2. The changes in correlation amplitude for this ti-
tration display the typical behavior of increasing slightly
before decreasing (13). Using TPE-FCS and TPE-FCCS,
G(0) values and diffusion coefficients red, green, and dually
labeled species were determined. These G(0) values could
then be used (Eq. 7) to calculate the fractional occupancy for
each titration point. These data were plotted and analyzed
using Eq. 9 to determine the equilibrium dissociation constant,
Kd, for each combination of fluorescence label (see Fig. 3).
Due to the low quantum yield of organic fluorophores and
the very low concentrations of biotin (ligand) required for
accurate determination of the experimental Kd values, only
QDs and fluorescent microspheres (FS) were suitable fluo-
rescent labels for biotin. AF 488 and 594 commercially
available organic fluorophores could be used as fluorescent
tags for the streptavidin receptor. At concentrations of ;10
nM, the AFS samples could be detected with reliability and
reproducibility. The AF-labeled streptavidin receptors are
only slightly larger than the native streptavidin having radii
of 3 and 2.5 nm, respectively (33). Thus, these conditions
allowed us to examine the full effect of bulky labeling on the
otherwise small ligand. Table 1 summarizes the experimental
hydrodynamic radii of the ligands and receptors in each of the
seven labeled systems examined. The values listed in Table
1 are the average values rounded to the nearest whole num-
ber. Importantly, these values agree within error to the man-
ufacturer’s specifications and were obtained from a minimum
of 20 different autocorrelation decay curves.
The experimentally obtained dissociation constants, Kd,
are presented in Table 2. One might imagine that the larger
the total size of the bound complex, the weaker the interac-
tion (as reflected by a larger Kd), but this is not the case. The
strongest binding pair is the streptavidin QD (8 nm diameter)
with the biotinylated fluospheres (40 nm diameter). From
Table 2 it is apparent that the smaller streptavidin labels lead
to stronger binding, but on the biotin side, the fluospheres
dominate the stronger binding. This suggests that the nature
of biotinylated surface is very important in determining
binding strength, which could be related to the freedom of
motion of the biotin and/or the environment the streptavidin
encounters when in proximity to the fluosphere. To help
decipher these streptavidin-biotin interactions, the contribu-
tions of on-rate kinetics were separated from the off-rate ki-
netics by measuring dissociation directly.
Binding kinetics
The off-rate kinetics for the series of binding pairs studied
above was examined using the previous approach for the
paired QD system (13). Briefly, equilibria were established
such that a 1:1 binding ratio dominated for streptavidin-biotin
pairs. Then a large excess of free d-biotin (;1 mM) was
added to the solution, and cross-correlation and autocorre-
lation decays were collected as a function of time after the
d-biotin addition. The correlation amplitudes were then used
to calculate the fractional occupancy, PA, which was then
normalized to time zero and plotted versus time (e.g., in Fig.
4). These plots were then fitted using Eq. 11 to determine koff.
The values of koff were then used to calculate the on-rate
constant for bind, kon. Both of these quantities are also pre-
sented in Table 2. One might anticipate that the off-rate ki-
netics would not depend on the size of the fluorescent tags
since this process is dictated more by the streptavidin binding
pocket. This is reflected by the data. The on-rate kinetics may
be more intimately related to the label size, since the collision
kinetics is influenced by the diffusion coefficients of the
colliding pair. However, as was earlier illustrated, the reac-
tion rate also will depend on the densities of the labels on the
nanoparticle surfaces (13).
It was demonstrated previously that the reduction of the
on-rate coefficient compared with the native streptavidin-
biotin binding can, in part, be accounted for by considering
the changes in the number of collisions which result in
FIGURE 2 (A) Cross-correlation de-
cays for the titration of 1 nM green
emitting streptavidin-coated fluospheres
with increasing volumes of 605 nm emis-
sion biotinylated QDs (from a 10 nM
stock QD solution). (B) Representative
data set and fit using Eq. 4.
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binding and the relative diffusion of the conjugates (13). The
most straightforward comparison between binding scenarios
can be made by taking the relation of the frequency factors,
A, for binding described by Arrhenius type kinetics (13):
konfree
konlabeled
¼ Afree
Alabeled
¼
ðrSBÞ 1
rS
1
1
rB
 
3 frac avail
ðrLSBÞ 1
rLS
1
1
rLB
 
3 frac avail
: (12)
The encounter distance is denoted by rSB (which represents
the radius of the colliding ligand), and receptor and rS(B) is
the hydrodynamic radius of the fluorescent species bearing
the streptavidin (biotin). Subscript L is the fluorescent-
labeled species measured. The values in the numerator are
for literature values of free streptavidin and biotin. The
fraction of the surface area of the labeled particle which is
available for binding is denoted ‘‘frac-avail’’. This factor
represents the fraction of the collisions in which the align-
ment of the ligand and receptor are in the correct orientation
for binding to occur. For the native system this value is close
to 1 (suggesting every collision will have the correct orien-
tation). However, the frac-avail can be very small (1) for
the labeled systems, since the nanoparticle surfaces have a
small fraction of streptavidin or biotin bound. Equation 13 is
used to calculate the fraction available for binding:
frac avail ¼
Yparticles
i¼1
nsites3
r
2
site
r
2
particle
 !
i
; (13)
where the number of binding sites/ligands per particle is
given by nsites, and rsite and rparticle are the radius of the
binding site/ligand and label, respectively. It is important to
note that for our model the frac-availwill be a product of both
particles involved in the collision: either unlabeled or labeled
biotin and streptavidin. Intuitively, the frac-avail for the
labeled system will be substantially smaller than the native
unlabeled system, as can be inferred from Fig. 1.
Using Eq. 13 it was possible to calculate the ratio of the-
oretical preexponential factors (Afree/Alabel) for the systems
assessed and compare them to native values. We found pre-
viously that this ratio did not entirely account for the differ-
ences observed in on-rate constants between the QD-labeled
streptavidin and biotin and the native system. Therefore, we
completed a more comprehensive study across fluorescent
labels of a variety of sizes.
FIGURE 3 Hill plot (Eq. 8 represents fitted line) of a titration of 1 nM
green emitting streptavidin-coated fluospheres with increasing volumes of
605 nm emission biotinylated QDs (Cligand). This plot gives a binding ratio
of 1:1 and Kd of 2.3 3 10
9 M.
TABLE 1 Experimental hydrodynamic radius for biotin and
streptavidin ligands and receptors examined in 100 mM
phosphate buffer
System
Hydrodynamic radius of
biotin (nm)
Hydrodynamic radius of
streptavidin (nm)
AFS-QDB 10 6 3 4 6 2
FSS-QDB 10 6 3 19 6 2
QDS-QDB 10 6 3 7 6 1
QDS-(40 nm) FSB 27 6 5 7 6 1
AFS-(40 nm) FSB 27 6 5 4 6 2
QDS-(200 nm) FSB 104 6 39 7 6 1
AFS-(200 nm) FSB 104 6 39 4 6 2
TABLE 2 Experimental dissociation constants, off-rate
constants, and calculated association rate constants in
100 mM phosphate buffer
System Kd (M) koff (s
1) kon (M
1s1)
AFS-QDB 4.3 3 10
10 4.0 3 105 9.3 3 104
FSS-QDB 2.3 3 10
9 3.4 3 105 1.5 3 104
QDS-QDB 4.0 3 10
10 4.0 3 105 1.0 3 105
QDS-(40 nm) FSB 1.3 3 10
10 3.4 3 104 2.6 3 106
AFS-(40 nm) FSB 2.8 3 10
10 1.4 3 104 5.0 3 105
QDS-(200 nm) FSB 1.9 3 10
10 4.0 3 104 2.1 3 106
AFS-(200 nm) FSB 1.4 3 10
10 1.1 3 104 7.9 3 105
FIGURE 4 Unbinding kinetics plot for a 1 nM QDB-FSS (1:1) solution
into which 100 mM free biotin has been added. The time zero normalized
fractional occupancy is plotted such that koff can be determined directly from
a fit using Eq. 12 (solid line).
870 Swift and Cramb
Biophysical Journal 95(2) 865–876
From Table 2, we directly observe that the decreased
translational diffusion coefficients of the labeled particles do
not completely account for the reduced association rate
constant. This simplified model does not take into account
rotational and orientational constraints for the large FS and
QD labels. Intuitively, one would expect that the conjugation
of the small ligand in particular could result in rotational
limitations which would contribute to the reduced overall
association rate for the labeled species.
Varying the size of ﬂuorescent label on biotin
and streptavidin biomolecules
From Table 2 it is evident that the bulky label on both the
ligand and the receptor contribute to the altered rate con-
stants, and upon initial inspection it is not evident whether a
definitive trend is identifiable. It is interesting that the largest
FSB ligand (200 nm) does not always result in the lowest
observed association rate constant. The origins of this are
unclear; however, it may be due to the large number of biotin
molecules conjugated to each of the spheres, which increase
the probability of a binding interaction occurring upon col-
lision. Again we are interested in determining if it is possible
to account for the reduced association of the dually labeled
systems using Eq. 12.
Table 3 summarizes the radii, number of binding sites,
frac-avail, and calculated ASB values for each of the labeled
systems investigated. For the AF-labeled and QD streptavidin,
the number of binding sites was estimated by carrying out a
blocking assay that determined the concentration of unla-
beled d-biotin necessary to completely block all binding with
QD-labeled biotin. The number of biotin molecules per QD
was based on manufacturers’ specifications. For the FSB and
FSS, values were calculated from binding data provided by
the supplier.
Table 4 compares the theoretical ratios of the frequency
factors to the experimentally derived ratio of rate constants.
Once more we note that the ratios of the experimental asso-
ciation rate constants for the free and labeled species are
much larger than the predicted values based on reduced
translational diffusion of the bulky labels in solution. For all
systems investigated the predicted ratio of Afree/Alabeled is
much smaller than the experimental ratio of free and labeled
association rate constants. From Table 4 it is evident that the
association rate constants (kon) are not purely governed by the
frequency factors, and thus the reaction is not purely diffu-
sion limited. Although this diffusion-based model may be an
oversimplification of the reduced biotin-streptavidin inter-
action in the presence of bulky labels, the model serves to
illustrate that the values we obtained for the association rate
constants are not unrealistic.
To reveal trends in the binding data, the constants pre-
sented in Tables 1 and 2 are plotted versus binding pair size in
Fig. 5. In this plot, the on-rate constant, kon, has been nor-
malized to remove its dependence on the number of binding
sites per particle pair. This was done by dividing by Afree/
Alabeled from Table 3. Therefore, if the constants depend only
on size, the kons should tend to decrease with size and the koffs
should be independent of size; and, therefore, the Kds should
increase with increasing particle size. A quick survey of Fig.
5 reveals that this is not the case.
The koffs (half-filled triangles) are considered first since
these are measured directly. The constants are grouped into
three categories based on the biotinylated species (40- and
200-nm-diameter fluospheres and 20-nm-diameter QDs). The
fluosphere data have the largest off-rates, with the FSB-QDS
pairs unbinding the fastest. This particular size effect may
suggest that for fluosphere-biotin, the environment of the
streptavidin dominates the unbinding process. This could
relate to the ability of free biotin to enter the streptavidin
pocket and/or to the energetic barrier to separation of the pair.
The pairs that include QDB are clustered together and have a
rate constant slower by an order of magnitude. The nature of
the streptavidin is less important, as all the koffs are clustered
close in value. For these combinations of smaller pairings,
the biotinylated QD seems to be the important factor. All the
pairings have rate constants larger than the value for the
native streptavidin-biotin pair (53 106 s1), but the smaller
pairs are closer to the native value.
Next we examine the equilibrium dissociation constants,
Kd (circles with cross-hatches), which are also measured
directly. In this case there is a slight trend of larger pairs
possessing smaller Kds, which means a thermodynamically
TABLE 3 Calculated theoretical frequency factors (ASB) for
native and labeled biotin-streptavidin binding systems in
100 mM phosphate buffer
System
nsites
(strept)
nsites
(biotin) frac-avail ASB
Afree/
Alabeled
Native (2) 4 1 0.16 1.67 -
AFS-QDB 3 6 2.5 3 10
4 1.2 3 103 1349
FSS-QDB 21 6 7.9 3 10
5 3.5 3 104 4812
QDS-QDB 10 6 8.4 3 10
4 4.1 3 103 405
QDS-(40 nm) FSB 10 148 9.3 3 10
4 5.7 3 103 293
AFS-(40 nm) FSB 3 148 8.6 3 10
4 7.6 3 103 220
QDS-(200 nm) FSB 10 18,540 7.8 3 10
3 1.3 3 101 13
AFS-(200 nm) FSB 3 18,540 7.2 3 10
2 2.0 3 101 8
TABLE 4 Experimental association rate constants and
theoretical frequency factors for native and labeled systems in
100 mM phosphate buffer
System
kon
(M1s1)
kfree/klabeled
(experimental)
Afree/Alabeled
(theoretical)
Native (2) 2.0 3 109 - -
AFS-QDB 9.3 3 10
4 21,505 1349
FSS-QDB 1.5 3 10
4 135,294 4812
QDS-QDB 1.0 3 10
5 20,000 405
QDS-(40 nm) FSB 2.6 3 10
6 765 293
AFS-(40 nm) FSB 5.0 3 10
5 4000 220
QDS-(200 nm)FSB 2.1 3 10
6 950 13
AFS-(200 nm)FSB 7.9 3 10
5 2532 8
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stronger bond. Pairs containing the FSB system have the
smallest Kds among the group. The least thermodynamically
stable is the FSS-QDB pairing. All the pairs have Kds that are
considerably larger (106–1043) than the native system.
The Kds and koffs were used to calculate the on-rate con-
stants for these combinations of labeled streptavidin and bi-
otin. The values were then normalized as mentioned above.
These are plotted in the topmost part of the graph and de-
lineated as x-ed squares. The general trends are counterin-
tuitive, from a size perspective, with the larger combinations
possessing larger on-rate constants. This is particularly in-
teresting for the large pairs with FSB as one of the partners.
The on-rate constants are one order of magnitude larger for
the FSB-QDS pair than for the FSB-AFS pair. The latter of
these has the streptavidin labeled with a small organic dye,
which one might think is less of a perturbation than the larger
QD. However, the organic dye perturbs the binding envi-
ronment more for these pairs (circled by green and black lines
in Fig. 5). The lowest kons come from the pairs with QDB as
one member of the binding pair—although in this data set
(within the red oval), there is a trend of larger species being
slower and thus reducing the rate constant. All told, it be-
comes clear from Fig. 5 that there is more than simply size
effects responsible for the changes in nanoparticle-labeled
streptavidin-biotin binding.
Schlosshauer and Baker have suggested that simply mul-
tiplying the diffusional component by the probability of a
collision resulting in binding, as we have done, is overly
naive (34). As an alternative, they presented a general ex-
pression for partially diffusion-controlled reactions which
occur between two spherical molecules, accounting for the
translation and rotation of the two particles. In the Schlos-
shauer and Baker model, the spherical molecules contain a
single asymmetric reactive area, which can be thought of as a
single receptor or ligand per sphere. Although their model is
considerably more sophisticated than the simple diffusion-
based model presented in Eq. 12, they report rate constants
which are two orders of magnitude larger than expected from
the simple geometric model presented here (34). From Table
4, we note that the ratio of observed rate constants (kfree/
klabeled) is much larger than the predicted ratio, except for
the QDS-FSB (40 nm) binding pair.
A theoretical rate constant obtained using the Schlosshauer
and Baker model would result in a larger denominator for the
predicted ratio and thus serves to increase the discrepancy
between the empirical and theoretical values. Furthermore,
their model assumes only a single asymmetric reactive
‘‘patch’’ on each of the spheres. In our experimental systems
both the streptavidin and biotinylated dots/spheres/fluo-
rophores have more than one reactive ligand/receptor on their
surface, making direct comparisons between the models
difficult. We have estimated that for the systems under study
here, rotation of the nanoparticles does not contribute sig-
nificantly to the differences in binding kinetics. Rotational
constraints become important when there is a single asym-
metric binding site on the large molecule. For a spherical
particle 10–100 nm in diameter with a larger number of
conjugated biomolecules, rotational constraints are not sig-
nificant. For the nanoparticle-labeled biotin-streptavidin in-
teraction, the angular momentum of the particles is large
enough that a number of potential ligands will encounter each
other during a single collision event.
Other microscopic properties contributing to reduced as-
sociation kinetics, including solvation and electrostatic ef-
FIGURE 5 Plots of the streptavidin-biotin
dissociation constant (Kd, crossed circles), off-
rate constant (koff, triangles), and normalized
on-rate constants (kon, crossed squares, normal-
ized to remove dependence of the number of
reactive sites per particle surface) versus sum of
the radii of the interacting pair. Data are
grouped according to the biotinylated species
with a red QD (red oval around data), green
40-nm-diameter fluosphere (green oval around
data) and green 200-nm-diameter fluosphere
(black oval around data). Within the plots the
streptavidin binding partners are given by a
green 40 nm fluosphere or red or green QDs.
The smallest binding partner is streptavidin
labeled with AF dyes. The details of the data
are found in Tables 1 and 2.
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fects, need to be considered. Indeed, there may be trends in
activation energies for the on and/or off reactions that are
connected with electrostatics and solvation in the surface
region of the particles.
Effect of total salt concentration on equilibrium
binding kinetics
Examining a series of nanoparticles joined by the streptavi-
din-biotin interaction as a function of solution ionic strength
can provide insight into surface-related effects that influence
association and dissociation kinetics. The systems which
were used for this analysis were QDS-QDB, QDS-FSB (40
nm), and QDS-FSB (200 nm). Each of the ligand-receptor
binding pairs were examined in 100 mM PB, 100 mM PB1
25 mM NaCl, and 100 mM PB 1 50 mM NaCl, resulting in
ionic strengths of 187.5, 212.5, and 262.5 mM, respectively.
The average diffusion constants and subsequent hydrody-
namic radius for each of the species were obtained for each
buffer system to account for any changes in hydration shell
with increased salt concentration. These experimentally de-
termined values are presented in Table 5. The average hy-
drodynamic radii were the same to within error for all
ligands/receptors examined in all the buffers used. Impor-
tantly, the consistency of the measured radii suggests also
that the viscosity of the buffer is not affected significantly by
the addition of increased salt.
Titration experiments were carried out as described pre-
viously for each of the systems (12). Kd and koff-rate constants
in addition to the calculated kon-rate constraints for each of the
systems are summarized in Tables 6–8. Results of Tables 6–8
were used to generate plots to compare the equilibrium
binding constants (Fig. 5) and dissociation rate constants
(Fig. 6) for each of the three systems.
In Fig. 6, we identify behavior for the QDS-QDB system
that is contrary to the two QDS-FSB systems. An increasedKd
for the QDS-QDB system is correlated to increased salt con-
centration, whereas both QDS-FSB systems result in smaller
Kd values, which begin to approach the native unlabeled
system. From the graph in Fig. 7, we note that for all three
cases examined the dissociation rate decreases with increased
ionic strength. Interestingly, Houen and Hansen (35) reported
that various sugars were found to interfere with the binding of
biotin and streptavidin. They attributed the reduced binding
to the interaction of the sugar moieties with side-chain resi-
dues in the binding pocket. NaCl would not form hydrogen
bonds with the tryptophan residues, which would be able to
interact strongly with the both the biotin ligand and sugars
molecules and thus should not affect the system in the same
manner.
From previous experiments done in our group, we know
that the fluospheres can be highly charged (36), and thus the
addition of salt to the solution would be expected to stabilize
the system by balancing the excess surface charges. One
would expect that if the dissolved salts were acting as
counterions in a stabilizing manner then increased total salt
concentrations should also result in an increase in the asso-
ciation rate for the FSB-QDS systems. A plot comparing the
association rate for each of the three systems as a function of
ionic strength is given in Fig. 8.
From Fig. 8 the calculated kon for all three systems indi-
cates that increased ionic strength is correlated with reduced
association rates, which does not support the hypothesis
presented above. As the salt readily dissolves in the buffer, it
is unlikely that the small concentration of NaCl added altered
the viscosity of the solution enough to account for the overall
reduced kon observed in Fig. 8. Moreover, there is no change
in the diffusion coefficients for this range of ionic strength.
For all three systems examined, the addition of increased
ionic strength lowers the koff and the kon at the same time.
Since the association becomes slower in both the forward and
reverse directions, it seems unlikely that the changes in ionic
TABLE 5 Hydrodynamic radii (nm) for each of the species as
a function of ionic strength
187.5 mM 212.5 mM 262.5 mM
QDS (525) 4 6 1 4 6 1 4 6 1
QDS (605) 7 6 1 5 6 1 5 6 1
QDB 10 6 3 8 6 2 10 6 2
FSB (40 nm) 27 6 6 28 6 6 28 6 7
FSB (200 nm) 104 6 39 106 6 39 102 6 33
TABLE 6 Equilibrium dissociation constant, dissociation rate
constant, and association rate constant for the QDS-QDB system
Ionic strength
(mM)
Experimental Kd
(M)
Experimental
koff (s
1)
Calculated kon
(M1s1)
187.5 4.0 6 0.4 3 1010 4.0 6 1.0 3 105 1.0 6 0.2 3 105
212.5 5.0 6 0.3 3 1010 4.0 6 0.8 3 105 8.0 6 1.0 3 104
262.5 7.0 6 0.3 3 1010 1.0 6 0.2 3 105 1.4 6 0.2 3 104
TABLE 7 Equilibrium dissociation constant, dissociation
rate constant, and association rate constant for the
QDS-FSB(40 nm) system
Ionic Strength
(mM)
Experimental Kd
(M)
Experimental
koff (s
1)
Calculated
kon (M
1s1)
187.5 1.3 6 0.7 3 1010 3.4 6 1.5 3 104 2.7 6 0.3 3 106
212.5 7.0 6 0.3 3 1011 1.2 6 0.7 3 104 1.7 6 0.3 3 106
262.5 3.0 6 1.0 3 1011 4.3 6 1.0 3 105 1.4 6 0.1 3 106
TABLE 8 Equilibrium dissociation constant, dissociation
rate constant, and association rate constant for the QDS-FSB
(200 nm) system
Ionic Strength
(mM)
Experimental Kd
(M)
Experimental
koff (s
1)
Calculated
kon (M
1s1)
187.5 2.3 6 0.06 3 1010 4.0 6 2.0 3 104 1.7 6 1.0 3 106
212.5 1.3 6 0.05 3 1010 1.6 6 0.7 3 104 1.2 6 0.6 3 106
262.5 1.2 6 0.7 3 1010 5.6 6 2.7 3 105 4.6 6 2.0 3 105
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strength significantly change the Coulombic interactions
between the particles, at least over the range of ionic strengths
employed. Given that the apparent sizes of the particles were
independent of ionic strength, it seems that significant
changes in solution viscosity do not occur either. Addition-
ally, since the streptavidin-biotin interaction can be consid-
ered the same in all cases, it seems unlikely that changes in
this interaction will dominate the trends in binding kinetics
and equilibria for the nanoparticle labels.
As the nanoparticles under investigation approach each
other, water molecules must rearrange to accommodate the
collisions. This can be thought of as a surface tension effect.
It is well known that increasing salt concentration leads to
increased surface tension for aqueous interfaces (37). Thus,
the energetic barrier to collisions increases with increasing
ionic strength, all other factors being essentially equal. This
would result in a smaller kon. A similar argument can be
applied to unbinding, where the barrier to water rearrange-
ment during nanoparticle-nanoparticle dissociation increases
with ionic strength. Thus, the rate constants decrease in both
the forward and reverse directions. This effect appears to be
independent of the nanoparticle pair studied.
In contrast to the rate constants, the equilibrium dissocia-
tion constant, Kd, gets smaller for QD-FS binding (i.e., be-
comes a stronger bond) and larger for QD-QD binding (i.e.,
becomes a weaker bond) as a function of increasing ionic
strength. The strengthening of the QD-FS interaction can be
rationalized again in terms of surface tension. There is a net
reduction in surface tension for the bound system, and this is
enhanced in the presence of increasing salt concentration.
The difference between the QD-FS and QD-QD interactions
is that for the latter both nanoparticles are coated with
FIGURE 6 Comparison of the equilibrium unbinding constants (Kd) for (A) QDS-QDB (black), (B) QDS-FSB 40 nm (blue), and QDS-FSB 200 nm (red) at
various ionic strengths.
FIGURE 7 Comparison of dissociation rate constants
(koff) for QDS-QDB (black), QDS-FSB 40 nm (blue), and
QDS-FSB 200 nm (red) for different ionic strengths.
Inset is an expanded version of the lowest plot.
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polyethylene glycol (PEG). Thus, the PEG structure must
also be taken into consideration for equilibrium binding.
These PEG-PEG interactions seem less influential on the ki-
netics, as discussed above. It has been demonstrated that a
PEG layer thins appreciably upon increasing ionic strength
in the range 2–200 mM (38). Although our range is much
smaller than this, it is possible that the increase in ionic
strength also hinders the mobility of the biotin on the QD-
PEG surface, reducing the binding probability and thus in-
creasing Kd.
CONCLUSIONS
We have demonstrated that the conjugation of bulky fluo-
rophores to both biotin and streptavidin has an effect on the
equilibrium and kinetics of this model system. This effect is
predominant in the association kinetics, or binding reactions,
which were found to be on average six orders of magnitude
slower than those of the native B-S system. The dissociation,
or off-rate constants, for the labeled B-S systems were only
;1 order of magnitude faster, at most, than the native system.
Larger ligands were shown to increase the rate of dissociation
for the B-S complex possibly through entropic surface me-
diated driving forces. Important corollaries of these results
reflect the need to choose carefully the size and type of flu-
orescent label chosen to study small ligands and receptors.
Countless examples exist in the literature where biotin and
streptavidin are used as a ‘‘bridge’’ or ‘‘molecular Velcro’’ to
link two different species of interest together.
When using this tight binding biotin and streptavidin
system, it is important to remember that binding is a dynamic
equilibrium while in solution. Conjugation of any species to
either biotin or streptavidin will alter the equilibrium, re-
ducing the association rate and/or increasing the dissociation
rate of the complex. As such, this interaction may not be the
molecular glue that is often quoted in the literature. Before
using the B-S interaction it would be advisable to obtain the
dissociation rate to understand the half-life of the complex.
This would allow the design of experiments that avoid dis-
sociation and allow increased time for association of the la-
beled/conjugated ligand-receptor complex.
In addition, we have shown that reduced association rates
for this particular tight binding pair cannot be explained
solely in terms of mesoscopic properties. Although the in-
creased ligand bulk does contribute to the reduced frequency
of binding events in solution, the reactions are not purely
diffusion limited. The limited salt studies carried out suggest
that there are surface tension effects at play for both binding
and unbinding.
Taken together, the results from our study suggest that
there are several effects of large fluorescent labels on the
dynamics and equilibria of biomolecular binding interac-
tions. These range from displacing equilibrium to altering the
on- and off-rate kinetics. The changes are due in part to the
sheer bulk of the labels and in part to the mesoscopic surface
properties of the labels. However, much of the change in
binding can be accounted for based on these two simple
considerations; and thus it appears that for streptavidin-biotin
binding, the integrity and function of the binding pair are not
drastically altered when conjugated to these bulky labels. In
effect, although the size of the nanoparticle does indeed
matter, one must also consider its other properties to under-
stand how a nanoparticle influences the chemistry of the
species it labels.
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